As organizations accredited by the ACCME, NFID and Medscape, LLC, require everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

NFID and Medscape, LLC, encourage Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Disclosed financial relationships have been reviewed by NFID to resolve any potential conflicts of interest. All faculty and planners have attested that the content of this activity will be based on the best available evidence; will promote quality healthcare, not a specific commercial interest; and will be well balanced and unbiased.

Author(s)

• Carol J. Baker, MD

  Professor of Pediatrics, Professor of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas; Staff Physician, Pediatric Infectious Diseases, Texas Children's Hospital, Houston, Texas

  Disclosures

  Disclosure: Carol J. Baker, MD, has disclosed no relevant financial relationships.
  
  Dr. Baker does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.
  
  Dr. Baker does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

• Loren G. Miller, MD, MPH

  Associate Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; Director, Infection Control Program, Harbor-UCLA Medical Center, Torrance, California

  Disclosures

  Disclosure: Loren G. Miller, MD, MPH, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Pfizer Inc.; Astellas Pharma, Inc.; Forest Laboratories, Inc.
  Received grants for clinical research from: Pfizer Inc.; Cubist Pharmaceuticals
  
  Dr. Miller does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr. Miller does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

• Robert A. Weinstein, MD

  Chief Operating Officer, CORE Center Interim Chairman, Department of Medicine, Cook County Hospital; Professor of Medicine, Rush Medical College, Chicago, Illinois

  Disclosures

  Disclosure: Robert A. Weinstein, MD, has disclosed no relevant financial relationships.
  
  Dr. Weinstein does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr. Weinstein does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

• Susan L. Smith, MN, PhD

  Scientific Director, Medscape, LLC

  Disclosures

  Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

Reviewer(s)

• Susan J. Rehm, MD

  Medical Director, National Foundation for Infectious Diseases, Bethesda, Maryland; Vice Chair, Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio

  Disclosures

  Disclosure: Susan J. Rehm, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Merck & Co. Inc.; Pfizer, Inc.; sanofi-pasteur
  Served as a speaker or a member of a speakers bureau for: Genentech, Inc.
  Received grants for clinical research from: Cubist Pharmaceuticals
  
  Dr. Rehm does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr. Rehm does not intend to discuss investigational uses of drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

CME Reviewer

• Lauren Ero, MS

  Director, Continuing Medical Education, National Foundation for Infectious Diseases, Bethesda, Maryland

  Disclosures

  Disclosure: Lauren Ero, MS, has disclosed no relevant financial relationships.

CE Reviewer

• Nafeez Zawahir, MD

  CME Clinical Director, Medscape, LLC

  Disclosures

  Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

• Susan L. Smith, MN, PhD

  Scientific Director, Medscape LLC

  Disclosures

  Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.